Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sherman Biotech is a specialized biotechnology company focused on the research, development, and large-scale production of hyaluronic acid (HA) and its derivatives. Based in Xiamen, China, the company utilizes advanced microbial fermentation and cross-linking technologies to manufacture medical, cosmetic, and food-grade sodium hyaluronate. Its product portfolio includes cross-linked HA dermal fillers, ophthalmic viscoelastics, and intra-articular injections for osteoarthritis. Sherman Biotech serves as a key supplier and contract manufacturer for global pharmaceutical and aesthetic companies, maintaining high-standard GMP facilities. The company is recognized for its high-purity HA production and its ability to customize molecular weights for specific clinical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sherman Biotech.